Abbott Laboratories (ABT)
114.11
-2.02
(-1.74%)
USD |
NYSE |
Aug 26, 16:00
114.11
0.00 (0.00%)
After-Hours: 16:57
Abbott Laboratories Net Income (Quarterly) : 928.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 928.00M |
| March 31, 2026 | 1.077B |
| December 31, 2025 | 1.80B |
| September 30, 2025 | 1.60B |
| June 30, 2025 | 1.80B |
| March 31, 2025 | 1.30B |
| December 31, 2024 | 9.195B |
| September 30, 2024 | 1.64B |
| June 30, 2024 | 1.297B |
| March 31, 2024 | 1.22B |
| December 31, 2023 | 1.588B |
| September 30, 2023 | 1.431B |
| June 30, 2023 | 1.37B |
| March 31, 2023 | 1.313B |
| December 31, 2022 | 1.029B |
| September 30, 2022 | 1.429B |
| June 30, 2022 | 2.009B |
| March 31, 2022 | 2.438B |
| December 31, 2021 | 1.981B |
| September 30, 2021 | 2.092B |
| June 30, 2021 | 1.184B |
| March 31, 2021 | 1.785B |
| December 31, 2020 | 2.147B |
| September 30, 2020 | 1.226B |
| June 30, 2020 | 534.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 541.00M |
| December 31, 2019 | 1.044B |
| September 30, 2019 | 954.00M |
| June 30, 2019 | 1.00B |
| March 31, 2019 | 668.00M |
| December 31, 2018 | 650.00M |
| September 30, 2018 | 548.00M |
| June 30, 2018 | 714.00M |
| March 31, 2018 | 406.00M |
| December 31, 2017 | -867.00M |
| September 30, 2017 | 558.00M |
| June 30, 2017 | 269.00M |
| March 31, 2017 | 384.00M |
| December 31, 2016 | 760.00M |
| September 30, 2016 | -357.00M |
| June 30, 2016 | 596.00M |
| March 31, 2016 | 55.00M |
| December 31, 2015 | 693.00M |
| September 30, 2015 | 593.00M |
| June 30, 2015 | 782.00M |
| March 31, 2015 | 518.00M |
| December 31, 2014 | 629.00M |
| September 30, 2014 | 438.00M |
| June 30, 2014 | 457.00M |
| March 31, 2014 | 337.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 451.00M |
| Boston Scientific Corp. | 905.00M |
| DexCom, Inc. | 249.10M |
| Insulet Corp. | 95.00M |
| Intuitive Surgical, Inc. | 823.20M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.59B |
| Total Expenses (Quarterly) | 11.66B |
| EPS Diluted (Quarterly) | 0.5324 |
| Enterprise Value | 228.61B |
| Gross Profit Margin (Quarterly) | 52.64% |
| Profit Margin (Quarterly) | 7.37% |
| Earnings Yield | 2.71% |
| Operating Earnings Yield | 3.84% |
| Normalized Earnings Yield | 2.733 |